#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hidradenitis Enteritis Bronchopulmonary dysplasia Albright's disease Alveolar proteinosis Primary mediastinal large B-cell lymphoma Hairy cell leukaemia Bulbospinal muscular atrophy congenital B-cell lymphoma recurrent Liposarcoma recurrent Desmoplastic small round cell tumour Anti-neutrophil cytoplasmic antibody positive vasculitis Pyruvate dehydrogenase complex deficiency Autoimmune hepatitis Craniocerebral injury More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Trials in Disease Hairy cell leukaemia recurrent Synovial sarcoma recurrent – Basic Information Hereditary motor and sensory neuropathy Nephrotic syndrome – Treatment Medulloblastoma recurrent – Trials in Disease Brain stem glioma – Basic Information Acquired haemophilia – Life with Disease Lymphangiosarcoma – Trials in Disease Burkitt’s lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MRNA-1345 Reparixin Tiotropium Bromide Calcium Zolbetuximab Esomeprazole Cilazapril Belinostat Lixisenatide Sodium Citrate Hct116-A Nemolizumab Ribitol Cabazitaxel Clofarabine Radium Ra 223 Dichloride Dalteparin Sodium Amiloride Tisagenlecleucel SILYMARIN More therapies…

    Learn about Your Condition

    Cervix carcinoma stage II Tinnitus Peritoneal dialysis Device related infection Shock Breast cancer male Magnetic resonance imaging Varices oesophageal Cytomegalovirus infection Migraine with aura Stress urinary incontinence Alveolar proteinosis Prader-Willi syndrome Skin wrinkling Chronic myeloid leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Topical delgocitinib safety study in patients with cutaneous T‑cell lymphoma (mycosis fungoides)

    Not yet recruiting

    2 1 1 1
    Denmark

  • A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Bulgaria Czechia Denmark Estonia +14

  • A Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Lichen sclerosus
    France Germany Italy Poland Spain

  • Phase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)

    Not yet recruiting

    3 1
    Belgium Bulgaria France Germany Greece Italy +4

  • Phase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo

    Not yet recruiting

    2 1
    France Germany Italy The Netherlands Spain

  • Indocyanine Green Fluorescence Imaging for Flap Perfusion in Head and Neck Cancer Reconstruction Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Indocyanine Green
    Sweden
Previous Page
1 … 21 22 23 24 25 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!